CD14 Immunophenotyping by Flow Cytometry Test
Comprehensive Introduction to CD14 Immunophenotyping
Immunophenotyping by Flow Cytometry CD14 Test represents a cutting-edge diagnostic approach that revolutionizes the detection and characterization of immune cells in clinical medicine. This sophisticated laboratory technique employs advanced flow cytometry technology to precisely identify and quantify CD14-positive cells, primarily monocytes and macrophages, which serve as critical components of the innate immune system. The importance of this test lies in its ability to provide clinicians with detailed information about immune cell populations, enabling accurate diagnosis, disease monitoring, and treatment evaluation for various hematological and immunological conditions.
What the CD14 Test Measures and Detects
The CD14 Immunophenotyping test specifically targets and measures:
- CD14 surface antigen expression levels on monocytes and macrophages
- Quantitative assessment of monocyte populations in peripheral blood
- Identification of abnormal CD14 expression patterns
- Detection of CD14-positive cell subsets in bone marrow
- Characterization of immune cell maturation and differentiation
Clinical Applications and Detection Capabilities
This advanced diagnostic tool can detect:
- Acute myeloid leukemia (AML) and other myeloid malignancies
- Monocytic leukemia variants
- Chronic myelomonocytic leukemia (CMML)
- Immune system disorders and inflammatory conditions
- Abnormal monocyte activation states
- Response to immunotherapy and targeted treatments
Who Should Consider CD14 Immunophenotyping Testing
This specialized test is recommended for individuals experiencing:
- Unexplained fever, night sweats, or persistent fatigue
- Unexplained weight loss and loss of appetite
- Recurrent infections or unusual susceptibility to infections
- Abnormal blood counts detected in routine testing
- Enlarged lymph nodes, spleen, or liver
- Bone pain or joint discomfort
- Skin rashes or unusual bruising
- Patients with suspected hematological malignancies
- Individuals undergoing cancer treatment monitoring
- Patients with autoimmune or inflammatory conditions
High-Risk Patient Groups
Particular consideration should be given to:
- Patients with family history of hematological cancers
- Individuals with previous abnormal blood test results
- Patients undergoing chemotherapy or immunotherapy
- Those with unexplained inflammatory markers
- Individuals with persistent immune system abnormalities
Significant Benefits of CD14 Immunophenotyping Testing
Choosing the CD14 Immunophenotyping test provides numerous advantages:
- Early Disease Detection: Identifies hematological malignancies at early stages when treatment is most effective
- Precise Diagnosis: Provides specific information about cell types and characteristics for accurate diagnosis
- Treatment Monitoring: Tracks response to therapy and detects minimal residual disease
- Rapid Results: Same-day reporting enables quick clinical decision-making
- Comprehensive Analysis: Offers detailed immune cell profiling beyond standard blood tests
- Personalized Medicine: Supports targeted treatment approaches based on specific cell markers
- Non-Invasive Option: Peripheral blood testing available as an alternative to bone marrow biopsy
Understanding Your CD14 Test Results
Interpreting CD14 immunophenotyping results requires professional medical expertise, but general guidance includes:
Normal Results Interpretation
- Normal CD14 expression patterns indicate typical monocyte populations
- Expected distribution of immune cell subsets
- Standard maturation patterns of myeloid cells
- Absence of abnormal cell populations
Abnormal Findings and Clinical Significance
- Increased CD14 expression may indicate monocyte activation or proliferation
- Decreased CD14 levels could suggest immune suppression or specific disorders
- Abnormal cell populations may indicate hematological malignancies
- Altered maturation patterns can suggest bone marrow disorders
- Presence of abnormal markers may require additional testing
Next Steps After Testing
- Discuss results with your hematologist or oncologist
- Follow recommended additional testing if indicated
- Implement treatment plans based on comprehensive findings
- Schedule appropriate follow-up monitoring
- Maintain regular communication with your healthcare team
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $88 |
| Regular Price | $112 |
Testing Process and Turnaround
- Sample Collection: Daily by 9 AM
- Report Availability: Same Day
- Sample Requirements: 3 mL whole blood in EDTA and Sodium Heparin tubes OR 2 mL bone marrow in Sodium Heparin tube
- Shipping Instructions: Immediate shipment at 18-22°C – DO NOT REFRIGERATE OR FREEZE
- Required Information: Complete clinical history and collection details
Nationwide Testing Availability
We proudly serve patients across the United States with comprehensive testing facilities in all major metropolitan areas. Our network includes specialized collection centers in:
- New York City and surrounding areas
- Los Angeles and Southern California
- Chicago and the Midwest region
- Houston and Texas locations
- Phoenix and Arizona facilities
- Philadelphia and East Coast centers
- All other major US cities and regions
Take Action for Your Health Today
Don’t wait to get the critical diagnostic information you need. Our CD14 Immunophenotyping by Flow Cytometry Test provides the advanced analysis required for accurate diagnosis and effective treatment planning. With same-day results and nationwide availability, we make advanced diagnostic testing accessible and convenient.
Call or WhatsApp us now at +1(267) 388-9828 to schedule your test or speak with our specialist team. Our experienced staff is ready to assist you with appointment scheduling, insurance questions, and any concerns you may have about the testing process.
Take the first step toward comprehensive health assessment and peace of mind. Book your CD14 Immunophenotyping test today and benefit from our advanced flow cytometry technology, expert interpretation, and commitment to patient care excellence.
